Advertisement

Iatrogenic Disease

  • Peter G. J. NikkelsEmail author

Abstract

Injury is a feature of all medical practice, but it is perhaps nowhere more accepted as an unavoidable consequence of therapy than in obstetric and neonatal medicine. Treatment is usually beneficial, but therapeutic procedures may sometimes result in adverse side effects or cause iatrogenic damage. Most side effects are minor problems, but some can be serious and may result in a major handicap, long-term sequelae, or death of the infant. Invasive antenatal investigation and treatment and the increasingly complex interventions in neonatology have resulted in the appearance of new types and patterns of pathology. Recognition of side effects, especially with the advent of newly developed therapeutic strategies in the neonatal intensive care unit, is very important, and the clinician must be alert and carefully monitor these children. This is important to minimize side effects and serious damage. The pathologist is sometimes the first to recognize these adverse effects but should be very well informed about the therapeutic interventions and therapies that were performed before beginning an examination to be able to recognize these side effects.

Keywords

Iatrogenic disease Iatrogenic pathology Lesions Amniocentesis Chorionic villus sampling (CVS) Cordocentesis Fetoscopy Fetal surgery Maternal drugs Teratogenic Organogenesis Over-the-counter medicines (OTCs) Birth injuries Cesarean section Neonatal therapy Infection Monitoring Vascular cannulation Blood sampling 

References

  1. 1.
    Anonymous. To err is human: building a safer health system. In: Kohn LT, Corrigan JM, Donaldson MS, editors. Washington, DC: National Academy Press; 2000.Google Scholar
  2. 2.
    Miller MR, Zhan C. Pediatric patient safety in hospitals: a national picture in 2000. Pediatrics. 2004;113:1741–6.PubMedGoogle Scholar
  3. 3.
    Kugelman A, Inbar-Sanado E, Shinwell ES, Makhoul IR, Leshem M, Zangen S, et al. Iatrogenesis in neonatal intensive care units: observational and interventional, prospective, multicenter study. Pediatrics. 2008;122:550–5.PubMedGoogle Scholar
  4. 4.
    Shojania KG, Burton EC, McDonald KM, Goldman L. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA. 2003;289:2849–56.PubMedGoogle Scholar
  5. 5.
    Srulovici E, Ore L, Shinwell ES, Blazer S, Zangen S, Riskin A, et al. Factors associated with iatrogenesis in neonatal intensive care units: an observational multicenter study. Eur J Pediatr. 2012;171:1753–9.PubMedGoogle Scholar
  6. 6.
    deSa D. Pathology of neonatal intensive care. An illustrated reference. London: Chapman & Hall Medical; 1995.Google Scholar
  7. 7.
    Jauniaux E, Rodeck C. Use, risks and complications of amniocentesis and chorionic villous sampling for prenatal diagnosis in early pregnancy. Early Pregnancy Biol Med. 1995;1:245–52.Google Scholar
  8. 8.
    Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies: a systematic review. Ultrasound Obstet Gynecol. 2012;40:128–34.Google Scholar
  9. 9.
    Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27:1–7.PubMedGoogle Scholar
  10. 10.
    van der Pol JG, Wolf H, Boer K, Treffers PE, Leschot NJ, Hey HA, et al. Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins. Br J Obstet Gynaecol. 1992;99:141–3.PubMedGoogle Scholar
  11. 11.
    Boyd PA, Keeling JW, Selinger M, Mackenzie IZ. Limb reduction and chorion villus sampling. Prenat Diagn. 1990;10:437–41.Google Scholar
  12. 12.
    Mastroiacovo P, Tozzi AE, Agosti S, Bocchino G, Bovicelli L, Dalpra L, et al. Transverse limb reduction defects after chorion villus sampling: a retrospective cohort study. Gidef–gruppo italiano diagnosi embrio-fetali. Prenat Diagn. 1993;13:1051–6.PubMedGoogle Scholar
  13. 13.
    Newnham JP, Doherty DA, Kendall GE, Zubrick SR, Landau LL, Stanley FJ. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomised controlled trial. Lancet. 2004;364:2038–44.PubMedGoogle Scholar
  14. 14.
    Stoch YK, Williams CJ, Granich J, Hunt AM, Landau LI, Newnham JP, et al. Are prenatal ultrasound scans associated with the autism phenotype? Follow-up of a randomised controlled trial. J Autism Dev Disord. 2012;42:2693–701.PubMedGoogle Scholar
  15. 15.
    Forward H, Yazar S, Hewitt AW, Khan J, Mountain JA, Pesudovs K, et al. Multiple prenatal ultrasound scans and ocular development: 20-year follow-up of a randomized controlled trial. Ultrasound Obstet Gynecol. 2014;44:166–70.Google Scholar
  16. 16.
    Merritt CR, Kremkau FW, Hobbins JC. Diagnostic ultrasound: bioeffects and safety. Ultrasound Obstet Gynecol. 1992;2:366–74.PubMedGoogle Scholar
  17. 17.
    Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34:5–12.PubMedGoogle Scholar
  18. 18.
    Tronnes H, Wilcox AJ, Lie RT, Markestad T, Moster D. Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: a national cohort study. Dev Med Child Neurol. 2014;56:779–85.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Alfirevic Z. Early amniocentesis versus transabdominal chorion villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2000;(2):CD000077.Google Scholar
  20. 20.
    Nikkila A, Valentin L, Thelin A, Jorgensen C. Early amniocentesis and congenital foot deformities. Fetal Diagn Ther. 2002;17:129–32.PubMedGoogle Scholar
  21. 21.
    Assel BG, Lewis SM, Dickerman LH, Park VM, Jassani MN. Single-operator comparison of early and mid-second-trimester amniocentesis. Obstet Gynecol. 1992;79:940–4.PubMedGoogle Scholar
  22. 22.
    Medda E, Donati S, Spinelli A, Di Renzo GC, EUROPOP Group Czech Republic, EUROPOP Group Finland, et al. Genetic amniocentesis: a risk factor for preterm delivery? Eur J Obstet Gynecol Reprod Biol. 2003;110:153–8.PubMedGoogle Scholar
  23. 23.
    Seeds JW. Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol. 2004;191:607–15.PubMedGoogle Scholar
  24. 24.
    Rushton DI. Examination of products of conception from previable human pregnancies. J Clin Pathol. 1981;34:819–35.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Therkelsen AJ, Rehder H. Intestinal atresia caused by second trimester amniocentesis. Case report. Br J Obstet Gynaecol. 1981;88:559–62.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Lamb MP. Gangrene of a fetal limb due to amniocentesis. Br J Obstet Gynaecol. 1975;82:829–30.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Rehder H, Weitzel H. Intrauterine amputations after amniocentesis. Lancet. 1978;1:382.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Strauss A, Hasbargen U, Paek B, Bauerfeind I, Hepp H. Intra-uterine fetal demise caused by amniotic band syndrome after standard amniocentesis. Fetal Diagn Ther. 2000;15:4–7.PubMedGoogle Scholar
  29. 29.
    Squier M, Chamberlain P, Zaiwalla Z, Anslow P, Oxbury J, Gould S, et al. Five cases of brain injury following amniocentesis in mid-term pregnancy. Dev Med Child Neurol. 2000;42:554–60.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986;1:1287–93.PubMedGoogle Scholar
  31. 31.
    Tabor A, Vestergaard CH, Lidegaard O. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol. 2009;34:19–24.Google Scholar
  32. 32.
    Fuhrmann W, Altland K, Kohler A, Holzgreve W, Jovanovic V, Rauskolb R, et al. Feto-maternal transfusion after chorionic villus sampling. Evaluation by maternal serum alphafetoprotein measurement. Hum Genet. 1988;78:83–5.PubMedGoogle Scholar
  33. 33.
    Stabile I, Warren R, Rodeck C, Grudzinskas JG. Measurements of placental, decidual, and fetal proteins before and after chorionic villus sampling. Prenat Diagn. 1988;8:387–91.PubMedGoogle Scholar
  34. 34.
    Firth HV, Boyd PA, Chamberlain P, MacKenzie IZ, Lindenbaum RH, Huson SM. Limb abnormalities and chorion villus sampling. Lancet. 1991;338:51.PubMedGoogle Scholar
  35. 35.
    Brambati B, Simoni G, Travi M, Danesino C, Tului L, Privitera O, et al. Genetic diagnosis by chorionic villus sampling before 8 gestational weeks: efficiency, reliability, and risks on 317 completed pregnancies. Prenat Diagn. 1992;12:789–99.PubMedGoogle Scholar
  36. 36.
    Burton BK, Schulz CJ, Burd LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol. 1992;79:726–30.PubMedGoogle Scholar
  37. 37.
    Schaap AH, van der Pol HG, Boer K, Leschot NJ, Wolf H. Long-term follow-up of infants after transcervical chorionic villus sampling and after amniocentesis to compare congenital abnormalities and health status. Prenat Diagn. 2002;22:598–604.PubMedGoogle Scholar
  38. 38.
    Orlandi F, Damiani G, Jakil C, Lauricella S, Bertolino O, Maggio A. The risks of early cordocentesis (12–21 weeks): analysis of 500 procedures. Prenat Diagn. 1990;10:425–8.PubMedGoogle Scholar
  39. 39.
    Johnstone-Ayliffe C, Prior T, Ong C, Regan F, Kumar S. Early procedure-related complications of fetal blood sampling and intrauterine transfusion for fetal anemia. Acta Obstet Gynecol Scand. 2012;91:458–62.PubMedGoogle Scholar
  40. 40.
    Nicolini U, Nicolaidis P, Fisk NM, Tannirandorn Y, Rodeck CH. Fetal blood sampling from the intrahepatic vein: analysis of safety and clinical experience with 214 procedures. Obstet Gynecol. 1990;76:47–53.PubMedGoogle Scholar
  41. 41.
    Maxwell DJ, Johnson P, Hurley P, Neales K, Allan L, Knott P. Fetal blood sampling and pregnancy loss in relation to indication. Br J Obstet Gynaecol. 1991;98:892–7.PubMedGoogle Scholar
  42. 42.
    Deprest JA, Flake AW, Gratacos E, Ville Y, Hecher K, Nicolaides K, et al. The making of fetal surgery. Prenat Diagn. 2010;30:653–67.PubMedGoogle Scholar
  43. 43.
    Transfusion WCGoT-t-T, Baschat A, Chmait RH, Deprest J, Gratacos E, Hecher K, et al. Twin-to-twin transfusion syndrome (TTTS). J Perinat Med. 2011;39:107–12.Google Scholar
  44. 44.
    Mann S, Johnson MP, Wilson RD. Fetal thoracic and bladder shunts. Semin Fetal Neonatal Med. 2010;15:28–33.PubMedGoogle Scholar
  45. 45.
    Gehring JE, Cain MP, Casale AJ, Kaefer M, Rink RC. Abdominal wall hernia: an uncommon complication of in utero vesicoamniotic shunt placement. Urology. 2000;56:330.PubMedGoogle Scholar
  46. 46.
    Morris RK, Malin GL, Quinlan-Jones E, Middleton LJ, Hemming K, Burke D, et al. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet. 2013;382:1496–506.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Deprest JA, Devlieger R, Srisupundit K, Beck V, Sandaite I, Rusconi S, et al. Fetal surgery is a clinical reality. Semin Fetal Neonatal Med. 2010;15:58–67.PubMedGoogle Scholar
  48. 48.
    Done E, Gratacos E, Nicolaides KH, Allegaert K, Valencia C, Castanon M, et al. Predictors of neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia undergoing fetoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2013;42:77–83.Google Scholar
  49. 49.
    Heerema AE, Rabban JT, Sydorak RM, Harrison MR, Jones KD. Lung pathology in patients with congenital diaphragmatic hernia treated with fetal surgical intervention, including tracheal occlusion. Pediatric Dev Pathol. 2003;6:536–46.Google Scholar
  50. 50.
    Van Mieghem T, Al-Ibrahim A, Deprest J, Lewi L, Langer JC, Baud D, et al. Minimally invasive therapy for fetal sacrococcygeal teratoma: case series and systematic review of the literature. Ultrasound Obstet Gynecology. 2014;43:611–9.Google Scholar
  51. 51.
    Danzer E, Sydorak RM, Harrison MR, Albanese CT. Minimal access fetal surgery. Eur J Obstet Gynecol Reprod Biol. 2003;108:3–13.PubMedGoogle Scholar
  52. 52.
    Deprest J, Emonds MP, Richter J, DeKoninck P, Van Mieghem T, Van Schoubroeck D, et al. Amniopatch for iatrogenic rupture of the fetal membranes. Prenat Diagn. 2011;31:661–6.PubMedGoogle Scholar
  53. 53.
    Sala P, Prefumo F, Pastorino D, Buffi D, Gaggero CR, Foppiano M, et al. Fetal surgery: an overview. Obstet Gynecol Surv. 2014;69:218–28.PubMedGoogle Scholar
  54. 54.
    Moldenhauer JS. In utero repair of spina bifida. Am J Perinatol. 2014;31:595–604.PubMedGoogle Scholar
  55. 55.
    Zamora IJ, Ethun CG, Evans LM, Olutoye OO, Ivey RT, Haeri S, et al. Maternal morbidity and reproductive outcomes related to fetal surgery. J Pediatr Surg. 2013;48:951–5.PubMedGoogle Scholar
  56. 56.
    Daud AN, Bergman JE, Bakker MK, Wang H, de Walle HE, Plosch T, et al. Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins. Pharmacogenomics. 2014;15:1029–41.PubMedGoogle Scholar
  57. 57.
    van Gelder MM, van Rooij IA, de Jong-van den Berg LT, Roeleveld N. Teratogenic mechanisms associated with prenatal medication exposure. Therapie. 2014;69:13–24.PubMedGoogle Scholar
  58. 58.
    Rubin PC. Prescribing in pregnancy. General principles. Br Med J. 1986;293:1415–7.Google Scholar
  59. 59.
    Brent RL. Environmental causes of human congenital malformations: the pediatrician’s role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics. 2004;113:957–68.PubMedGoogle Scholar
  60. 60.
    Brent RL, Beckman DA, Landel CP. Clinical teratology. Curr Opin Pediatr. 1993;5:201–11.PubMedGoogle Scholar
  61. 61.
    Bishop JB, Witt KL, Sloane RA. Genetic toxicities of human teratogens. Mutat Res. 1997;396:9–43.PubMedGoogle Scholar
  62. 62.
    Ghanooni M, Mattison DR, Zhang YP, Macina OT, Rosenkranz HS, Klopman G. Structural determinants associated with risk of human developmental toxicity. Am J Obstet Gynecol. 1997;176:799–805.PubMedGoogle Scholar
  63. 63.
    Mitchell AA. Adverse drug reactions in utero: perspectives on teratogens and strategies for the future. Clin Pharmacol Ther. 2011;89:781–3.PubMedGoogle Scholar
  64. 64.
    Rubin P. Fortnightly review: drug treatment during pregnancy. BMJ. 1998;317:1503–6.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193:771–7.PubMedGoogle Scholar
  66. 66.
    Pastore LM, Hertz-Picciotto I, Beaumont JJ. Risk of stillbirth from medications, illnesses and medical procedures. Paediatr Perinat Epidemiol. 1999;13:421–30.PubMedGoogle Scholar
  67. 67.
    Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician. 2003;67:2517–24.PubMedGoogle Scholar
  68. 68.
    Leck IM, Millar EL. Incidence of malformations since the introduction of thalidomide. Br Med J. 1962;2:16–20.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Thiersch JB. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A.) administered by the oral route. Am J Obstet Gynecol. 1952;63:1298–304.Google Scholar
  70. 70.
    Milunsky A, Graef JW, Gaynor Jr MF. Methotrexate-induced congenital malformations. J Pediatr. 1968;72:790–5.PubMedGoogle Scholar
  71. 71.
    Kozma C, Ramasethu J. Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations. Am J Med Genet A. 2011;155A:1723–8.PubMedGoogle Scholar
  72. 72.
    Meadow SR. Anticonvulsant drugs and congenital abnormalities. Lancet. 1968;2:1296.PubMedGoogle Scholar
  73. 73.
    Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet. 1972;2:839–43.PubMedGoogle Scholar
  74. 74.
    Monson RR, Rosenberg L, Hartz SC, Shapiro S, Heinonen OP, Slone D. Diphenylhydantoin and selected congenital malformations. N Engl J Med. 1973;289:1049–52.PubMedGoogle Scholar
  75. 75.
    Hill RM, Verniaud WM, Horning MG, McCulley LB, Morgan NF. Infants exposed in utero to antiepileptic drugs. A prospective study. Am J Dis Child. 1974;127:645–53.PubMedGoogle Scholar
  76. 76.
    Eadie MJ. Antiepileptic drugs as human teratogens. Expert Opin Drug Saf. 2008;7:195–209.PubMedGoogle Scholar
  77. 77.
    Meador KJ, Penovich P, Baker GA, Pennell PB, Bromfield E, Pack A, et al. Antiepileptic drug use in women of childbearing age. Epilepsy Behav. 2009;15:339–43.Google Scholar
  78. 78.
    Wilffert B, Altena J, Tijink L, van Gelder MM, de Jong-van den Berg LT. Pharmacogenetics of drug-induced birth defects: what is known so far? Pharmacogenomics. 2011;12:547–58.PubMedGoogle Scholar
  79. 79.
    Mann MW, Pons G. Various pharmacogenetic aspects of antiepileptic drug therapy: a review. CNS Drugs. 2007;21:143–64.PubMedGoogle Scholar
  80. 80.
    Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med. 1990;322:1567–72.PubMedGoogle Scholar
  81. 81.
    Finnell RH, Chernoff GF. Genetic background: the elusive component in the fetal hydantoin syndrome. Am J Med Genet. 1984;19:459–62.PubMedGoogle Scholar
  82. 82.
    Strickler SM, Dansky LV, Miller MA, Seni MH, Andermann E, Spielberg SP. Genetic predisposition to phenytoin-induced birth defects. Lancet. 1985;2:746–9.PubMedGoogle Scholar
  83. 83.
    Becker MH, Genieser NB, Finegold M, Miranda D, Spackman T. Chondrodysplasis punctata: is maternal warfarin therapy a factor? Am J Dis Child. 1975;129:356–9.PubMedGoogle Scholar
  84. 84.
    Pauli RM, Hall JG. Warfarin embryopathy. Lancet. 1979;2:144.PubMedGoogle Scholar
  85. 85.
    Raghav S, Reutens D. Neurological sequelae of intrauterine warfarin exposure. J Clin Neurosci. 2007;14:99–103.PubMedGoogle Scholar
  86. 86.
    Agarwal M, Phadke SR. Atlantoaxial dislocation in a child affected by warfarin embryopathy: a case report. Clin Dysmorphol. 2013;22:124–6.PubMedGoogle Scholar
  87. 87.
    Wainwright H, Beighton P. Warfarin embryopathy: fetal manifestations. Virchows Arch Int J Pathol. 2010;457:735–9.Google Scholar
  88. 88.
    Wellesley D, Moore I, Heard M, Keeton B. Two cases of warfarin embryopathy: a re-emergence of this condition? Br J Obstet Gynaecol. 1998;105:805–6.PubMedGoogle Scholar
  89. 89.
    Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122–40.PubMedPubMedCentralGoogle Scholar
  90. 90.
    Rosa FW. Teratogenicity of isotretinoin. Lancet. 1983;2:513.PubMedGoogle Scholar
  91. 91.
    Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313:837–41.PubMedPubMedCentralGoogle Scholar
  92. 92.
    Barr Jr M, Cohen Jr MM. Ace inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology. 1991;44:485–95.PubMedGoogle Scholar
  93. 93.
    Plazanet C, Arrondel C, Chavant F, Gubler MC. Fetal renin-angiotensin-system blockade syndrome: renal lesions. Pediatr Nephrol. 2014;29:1221–30.PubMedGoogle Scholar
  94. 94.
    Cunniff C, Jones KL, Phillipson J, Benirschke K, Short S, Wujek J. Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. Am J Obstet Gynecol. 1990;162:187–9.PubMedGoogle Scholar
  95. 95.
    O’Brien PC, Noller KL, Robboy SJ, Barnes AB, Kaufman RH, Tilley BC, et al. Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet Gynecol. 1979;53:300–8.PubMedGoogle Scholar
  96. 96.
    Reed CE, Fenton SE. Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects. Birth Defects Res C Embryo Today. 2013;99:134–46.PubMedGoogle Scholar
  97. 97.
    Palmer JR, Herbst AL, Noller KL, Boggs DA, Troisi R, Titus-Ernstoff L, et al. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health. 2009;8:37.Google Scholar
  98. 98.
    Raman-Wilms L, Tseng AL, Wighardt S, Einarson TR, Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol. 1995;85:141–9.PubMedGoogle Scholar
  99. 99.
    Koenig D, Spreux A, Hieronimus S, Chichmanian RM, Bastiani F, Fenichel P, et al. Birth defects observed with maternal carbimazole treatment: six cases reported to Nice’s Pharmacovigilance Center. Ann Endocrinol. 2010;71:535–42.Google Scholar
  100. 100.
    Low LC, Ratcliffe WA, Alexander WD. Intrauterine hypothyroidism due to antithyroid-drug therapy for thyrotoxicosis during pregnancy. Lancet. 1978;2:370–1.PubMedGoogle Scholar
  101. 101.
    Mazzaferri EL. Evaluation and management of common thyroid disorders in women. Am J Obstet Gynecol. 1997;176:507–14.PubMedGoogle Scholar
  102. 102.
    Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990;301:587–9.PubMedPubMedCentralGoogle Scholar
  103. 103.
    Heida KY, Zeeman GG, Van Veen TR, Hulzebos CV. Neonatal side effects of maternal labetalol treatment in severe preeclampsia. Early Hum Dev. 2012;88:503–7.PubMedGoogle Scholar
  104. 104.
    Sachs HC, Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013;132:e796–809.PubMedGoogle Scholar
  105. 105.
    Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet. 1988;14:217–40.PubMedGoogle Scholar
  106. 106.
    Graham Jr JM, Edwards MJ, Edwards MJ. Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans. Teratology. 1998;58:209–21.PubMedGoogle Scholar
  107. 107.
    Edwards MJ, Shiota K, Smith MS, Walsh DA. Hyperthermia and birth defects. Reprod Toxicol. 1995;9:411–25.PubMedGoogle Scholar
  108. 108.
    Tiboni GM, Iammarrone E, Piccirillo G, Liberati M, Bellati U. Aspirin pretreatment potentiates hyperthermia-induced teratogenesis in the mouse. Am J Obstet Gynecol. 1998;178:270–9.PubMedGoogle Scholar
  109. 109.
    Edwards MJ. Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer. Where are the common links? Cell Stress Chaperones. 1998;3:213–20.PubMedPubMedCentralGoogle Scholar
  110. 110.
    Noorlander CW, Visser GH, Ramakers GM, Nikkels PG, de Graan PN. Prenatal corticosteroid exposure affects hippocampal plasticity and reduces lifespan. Dev Neurobiol. 2008;68:237–46.PubMedGoogle Scholar
  111. 111.
    Seckl JR. Glucocorticoids, developmental ‘programming’ and the risk of affective dysfunction. Prog Brain Res. 2008;167:17–34.PubMedGoogle Scholar
  112. 112.
    Singh RR, Cuffe JS, Moritz KM. Short- and long-term effects of exposure to natural and synthetic glucocorticoids during development. Clin Exp Pharmacol Physiol. 2012;39:979–89.PubMedGoogle Scholar
  113. 113.
    Dodic M, Moritz K, Koukoulas I, Wintour EM. Programmed hypertension: kidney, brain or both? Trends Endocrinol Metab. 2002;13:403–8.PubMedGoogle Scholar
  114. 114.
    Matthews SG, Owen D, Banjanin S, Andrews MH. Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth. Endocr Res. 2002;28:709–18.PubMedGoogle Scholar
  115. 115.
    Noorlander CW, Ververs FF, Nikkels PG, van Echteld CJ, Visser GH, Smidt MP. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One. 2008;3, e2782.PubMedPubMedCentralGoogle Scholar
  116. 116.
    Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579–87.PubMedGoogle Scholar
  117. 117.
    Towers CV, Briggs GG. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol. 2002;187:495–500.PubMedGoogle Scholar
  118. 118.
    Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol. 1998;179:879–83.PubMedGoogle Scholar
  119. 119.
    Thorp JA. Epidural analgesia during labor. Clin Obstet Gynecol. 1999;42:785–801.PubMedGoogle Scholar
  120. 120.
    Gizzo S, Noventa M, Fagherazzi S, Lamparelli L, Ancona E, Di Gangi S, et al. Update on best available options in obstetrics anaesthesia: perinatal outcomes, side effects and maternal satisfaction. Fifteen years systematic literature review. Arch Gynecol Obstet. 2014;290:21–34.PubMedGoogle Scholar
  121. 121.
    Alexander JM, Lucas MJ, Ramin SM, McIntire DD, Leveno KJ. The course of labor with and without epidural analgesia. Am J Obstet Gynecol. 1998;178:516–20.PubMedGoogle Scholar
  122. 122.
    Newton ER, Schroeder BC, Knape KG, Bennett BL. Epidural analgesia and uterine function. Obstet Gynecol. 1995;85:749–55.PubMedGoogle Scholar
  123. 123.
    Poole JH. Analgesia and anesthesia during labor and birth: implications for mother and fetus. J Obstet Gynecol Neonatal Nurs. 2003;32:780–93.Google Scholar
  124. 124.
    Smiley R. Introduction. Special topics in obstetric anesthesia. Semin Perinatol. 2014;38:327–8.PubMedGoogle Scholar
  125. 125.
    Wigglesworth J. Pathology of intrapartum and early neonatal death in the normally formed infant. In: Wigglesworth J, editor. Textbook of fetal and perinatal pathology. 2nd ed. Oxford: Blackwell Scientific Publications; 1998. p. 251–68.Google Scholar
  126. 126.
    O’Mahony F, Settatree R, Platt C, Johanson R. Review of singleton fetal and neonatal deaths associated with cranial trauma and cephalic delivery during a national intrapartum-related confidential enquiry. BJOG. 2005;112:619–26.PubMedPubMedCentralGoogle Scholar
  127. 127.
    Amar AP, Aryan HE, Meltzer HS, Levy ML. Neonatal subgaleal hematoma causing brain compression: report of two cases and review of the literature. Neurosurgery. 2003;52:1470–4.Google Scholar
  128. 128.
    Zelson C, Lee SJ, Pearl M. The incidence of skull fractures underlying cephalohematomas in newborn infants. J Pediatr. 1974;85:371–3.PubMedGoogle Scholar
  129. 129.
    Bofill JA, Rust OA, Devidas M, Roberts WE, Morrison JC, Martin Jr JN. Neonatal cephalohematoma from vacuum extraction. J Reprod Med. 1997;42:565–9.PubMedGoogle Scholar
  130. 130.
    Florentino-Pineda I, Ezhuthachan SG, Sineni LG, Kumar SP. Subgaleal hemorrhage in the newborn infant associated with silicone elastomer vacuum extractor. J Perinatol. 1994;14:95–100.Google Scholar
  131. 131.
    Benaron DA. Subgaleal hematoma causing hypovolemic shock during delivery after failed vacuum extraction: a case report. J Perinatol. 1993;13:228–31.Google Scholar
  132. 132.
    Govaert P, Vanhaesebrouck P, De Praeter C, Moens K, Leroy J. Vacuum extraction, bone injury and neonatal subgaleal bleeding. Eur J Pediatr. 1992;151:532–5.PubMedGoogle Scholar
  133. 133.
    Hickey K, McKenna P. Skull fracture caused by vacuum extraction. Obstet Gynecol. 1996;88:671–3.PubMedGoogle Scholar
  134. 134.
    Dupuis O, Silveira R, Dupont C, Mottolese C, Kahn P, Dittmar A, et al. Comparison of “instrument-associated” and “spontaneous” obstetric depressed skull fractures in a cohort of 68 neonates. Am J Obstet Gynecol. 2005;192:165–70.PubMedPubMedCentralGoogle Scholar
  135. 135.
    Huisman TA, Fischer J, Willi UV, Eich GF, Martin E. “Growing fontanelle”: a serious complication of difficult vacuum extraction. Neuroradiology. 1999;41:381–3.PubMedGoogle Scholar
  136. 136.
    Wigglesworth JS, Husemeyer RP. Intracranial birth trauma in vaginal breech delivery: the continued importance of injury to the occipital bone. Br J Obstet Gynaecol. 1977;84:684–91.PubMedPubMedCentralGoogle Scholar
  137. 137.
    Currarino G. Occipital osteodiastasis: presentation of four cases and review of the literature. Pediatr Radiol. 2000;30:823–9.PubMedGoogle Scholar
  138. 138.
    Whitby EH, Griffiths PD, Rutter S, Smith MF, Sprigg A, Ohadike P, et al. Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet. 2004;363:846–51.Google Scholar
  139. 139.
    Hall SL. Simultaneous occurrence of intracranial and subgaleal hemorrhages complicating vacuum extraction delivery. J Perinatol. 1992;12:185–7.Google Scholar
  140. 140.
    Castillo M, Fordham LA. MR of neurologically symptomatic newborns after vacuum extraction delivery. AJNR 1995;16:816–8.Google Scholar
  141. 141.
    Petrikovsky BM, Schneider E, Smith-Levitin M, Gross B. Cephalhematoma and caput succedaneum: do they always occur in labor? Am J Obstet Gynecol. 1998;179:906–8.PubMedGoogle Scholar
  142. 142.
    Gunn TR, Becroft DM. Fetal subdural hematoma before labor. Am J Obstet Gynecol. 1991;164:934–5.PubMedGoogle Scholar
  143. 143.
    Gunn TR, Becroft DM. Unexplained intracranial haemorrhage in utero: the battered fetus? Aust N Z J Obstet Gynaecol. 1984;24:17–22.PubMedGoogle Scholar
  144. 144.
    Demir RH, Gleicher N, Myers SA. Atraumatic antepartum subdural hematoma causing fetal death. Am J Obstet Gynecol. 1989;160:619–20.PubMedGoogle Scholar
  145. 145.
    Pilalis A, Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. Prenatal diagnosis of atraumatic fetal subdural hematoma. Am J Obstet Gynecol. 2003;189:882–3.PubMedGoogle Scholar
  146. 146.
    Meagher SE, Walker SP, Choong S. Mid-trimester fetal subdural hemorrhage: prenatal diagnosis. Ultrasound Obstet Gynecol. 2002;20:296–8.PubMedGoogle Scholar
  147. 147.
    Perlow JH, Wigton T, Hart J, Strassner HT, Nageotte MP, Wolk BM. Birth trauma. A five-year review of incidence and associated perinatal factors. J Reprod Med. 1996;41:754–60.PubMedGoogle Scholar
  148. 148.
    Gherman R. Persistent brachial plexus injury: the outcome of concern among patients with suspected fetal macrosomia. Am J Obstet Gynecol. 1998;178:195–6.PubMedGoogle Scholar
  149. 149.
    Beall MH, Ross MG. Clavicle fracture in labor: risk factors and associated morbidities. J Perinatol. 2001;21:513–5.PubMedGoogle Scholar
  150. 150.
    Kaplan B, Rabinerson D, Avrech OM, Carmi N, Steinberg DM, Merlob P. Fracture of the clavicle in the newborn following normal labor and delivery. Int J Gynaecol Obstetrics. 1998;63:15–20.Google Scholar
  151. 151.
    Cohen AW, Otto SR. Obstetric clavicular fractures. A three-year analysis. J Reprod Med. 1980;25:119–22.PubMedGoogle Scholar
  152. 152.
    Iskender C, Kaymak O, Erkenekli K, Ustunyurt E, Uygur D, Yakut HI, et al. Neonatal injury at cephalic vaginal delivery: a retrospective analysis of extent of association with shoulder dystocia. PLoS One. 2014;9, e104765.PubMedPubMedCentralGoogle Scholar
  153. 153.
    Vialle R, Pietin-Vialle C, Ilharreborde B, Dauger S, Vinchon M, Glorion C. Spinal cord injuries at birth: a multicenter review of nine cases. J Matern-Fetal Neonatal Med. 2007;20:435–40.Google Scholar
  154. 154.
    Yates PO. Birth trauma to the vertebral arteries. Arch Dis Child. 1959;34:436–41.PubMedPubMedCentralGoogle Scholar
  155. 155.
    Goetz E. Neonatal spinal cord injury after an uncomplicated vaginal delivery. Pediatr Neurol. 2010;42:69–71.PubMedGoogle Scholar
  156. 156.
    Murty VS, Ram KD. Phrenic nerve palsy: a rare cause of respiratory distress in newborn. J Pediatr Neurosci. 2012;7:225–7.PubMedPubMedCentralGoogle Scholar
  157. 157.
    Doumouchtsis SK, Arulkumaran S. Are all brachial plexus injuries caused by shoulder dystocia? Obstet Gynecol Surv. 2009;64:615–23.PubMedGoogle Scholar
  158. 158.
    Mollberg M, Hagberg H, Bager B, Lilja H, Ladfors L. High birthweight and shoulder dystocia: the strongest risk factors for obstetrical brachial plexus palsy in a swedish population-based study. Acta Obstet Gynecol Scand. 2005;84:654–9.PubMedGoogle Scholar
  159. 159.
    Hughes CA, Harley EH, Milmoe G, Bala R, Martorella A. Birth trauma in the head and neck. Arch Otolaryngol Head Neck Surg. 1999;125:193–9.PubMedGoogle Scholar
  160. 160.
    Mehta SH, Blackwell SC, Bujold E, Sokol RJ. What factors are associated with neonatal injury following shoulder dystocia? J Perinatol. 2006;26:85–8.PubMedGoogle Scholar
  161. 161.
    Sjoberg I, Erichs K, Bjerre I. Cause and effect of obstetric (neonatal) brachial plexus palsy. Acta Paediatr Scand. 1988;77:357–64.PubMedGoogle Scholar
  162. 162.
    Wilkinson C, McIlwaine G, Boulton-Jones C, Cole S. Is a rising caesarean section rate inevitable? Br J Obstet Gynaecol. 1998;105:45–52.PubMedGoogle Scholar
  163. 163.
    Crowther CA, Dodd JM, Hiller JE, Haslam RR, Robinson JS, Birth After Caesarean Study Group. Planned vaginal birth or elective repeat caesarean: patient preference restricted cohort with nested randomised trial. PLoS Med. 2012;9:e1001192.PubMedPubMedCentralGoogle Scholar
  164. 164.
    Many A, Helpman L, Vilnai Y, Kupferminc MJ, Lessing JB, Dollberg S. Neonatal respiratory morbidity after elective cesarean section. J Matern-Fetal Neonatal Med. 2006;19:75–8.Google Scholar
  165. 165.
    Parilla BV, Dooley SL, Jansen RD, Socol ML. Iatrogenic respiratory distress syndrome following elective repeat cesarean delivery. Obstet Gynecol. 1993;81:392–5.PubMedGoogle Scholar
  166. 166.
    Gerten KA, Coonrod DV, Bay RC, Chambliss LR. Cesarean delivery and respiratory distress syndrome: does labor make a difference? Am J Obstet Gynecol. 2005;193:1061–4.PubMedGoogle Scholar
  167. 167.
    Olver RE, Walters DV, Wilson SM. Developmental regulation of lung liquid transport. Ann Rev Physiol. 2004;66:77–101.Google Scholar
  168. 168.
    Barker PM, Olver RE. Invited review: clearance of lung liquid during the perinatal period. J Appl Physiol. 2002;93:1542–8.PubMedGoogle Scholar
  169. 169.
    Saunders RA, Milner AD. Pulmonary pressure/volume relationships during the last phase of delivery and the first postnatal breaths in human subjects. J Pediatr. 1978;93:667–73.PubMedGoogle Scholar
  170. 170.
    Vyas H, Field D, Milner AD, Hopkin IE. Determinants of the first inspiratory volume and functional residual capacity at birth. Pediatr Pulmonol. 1986;2:189–93.PubMedGoogle Scholar
  171. 171.
    Chiswick ML, Milner RD. Crying vital capacity. Measurement of neonatal lung function. Arch Dis Child. 1976;51:22–7.PubMedPubMedCentralGoogle Scholar
  172. 172.
    Saunders RA, Milner AD, Hopkin IE. A study of the role of air trapping in the establishment of the functional residual capacity by analysis of pressure/volume and flow/volume loops. Early Hum Dev. 1978;2:107–14.PubMedGoogle Scholar
  173. 173.
    Sardesai SR, Kornacka MK, Walas W, Ramanathan R. Iatrogenic skin injury in the neonatal intensive care unit. J Matern-Fetal Neonatal Med. 2011;24:197–203.Google Scholar
  174. 174.
    Ligi I, Arnaud F, Jouve E, Tardieu S, Sambuc R, Simeoni U. Iatrogenic events in admitted neonates: a prospective cohort study. Lancet. 2008;371:404–10.PubMedGoogle Scholar
  175. 175.
    Fearne JM, Bryan EM, Elliman AM, Brook AH, Williams DM. Enamel defects in the primary dentition of children born weighing less than 2000 g. Br Dent J. 1990;168:433–7.PubMedGoogle Scholar
  176. 176.
    Fadavi S, Adeni S, Dziedzic K, Punwani I, Vidyasagar D. The oral effects of orotracheal intubation in prematurely born preschoolers. ASDC J Dent Child. 1992;59:420–4.PubMedGoogle Scholar
  177. 177.
    Powaser MM, Brown MC, Chezem J, Woodburne CR, Rogenes P, Hanson B. The effectiveness of hourly cuff deflation in minimizing tracheal damage. Heart Lung J Crit Care. 1976;5:734–41.Google Scholar
  178. 178.
    Pape KE, Armstrong DL, Fitzhardinge PM. Central nervous system pathology associated with mask ventilation in the very low birthweight infant: a new etiology for intracerebellar hemorrhages. Pediatrics. 1976;58:473–83.PubMedGoogle Scholar
  179. 179.
    Wei JL, Bond J. Management and prevention of endotracheal intubation injury in neonates. Curr Opin Otolaryngol Head Neck Surg. 2011;19:474–7.PubMedGoogle Scholar
  180. 180.
    Sapin E, Gumpert L, Bonnard A, Carricaburu E, Sava E, Contencin P, et al. Iatrogenic pharyngoesophageal perforation in premature infants. Eur J Pediatr Surg. 2000;10:83–7.PubMedGoogle Scholar
  181. 181.
    Liu H, Chen JC, Holinger LD, Gonzalez-Crussi F. Histopathologic fundamentals of acquired laryngeal stenosis. Pediatric Pathol Lab Med. 1995;15:655–77.Google Scholar
  182. 182.
    O’Neill Jr JA. Experience with iatrogenic laryngeal and tracheal stenoses. J Pediatr Surg. 1984;19:235–8.PubMedGoogle Scholar
  183. 183.
    Gould SJ, Howard S. The histopathology of the larynx in the neonate following endotracheal intubation. J Pathol. 1985;146:301–11.PubMedPubMedCentralGoogle Scholar
  184. 184.
    Downing GJ, Hayen LK, Kilbride HW. Acquired subglottic cysts in the low-birth-weight infant. Characteristics, treatment, and outcome. Am J Dis Child. 1993;147:971–4.PubMedGoogle Scholar
  185. 185.
    Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr. 1979;95:865–6.PubMedGoogle Scholar
  186. 186.
    Weisz DE, McNamara PJ. Patent ductus arteriosus ligation and adverse outcomes: causality or bias? J Clin Neonatol. 2014;3:67–75.PubMedPubMedCentralGoogle Scholar
  187. 187.
    Zbar RI, Chen AH, Behrendt DM, Bell EF, Smith RJ. Incidence of vocal fold paralysis in infants undergoing ligation of patent ductus arteriosus. Ann Thorac Surg. 1996;61:814–6.PubMedGoogle Scholar
  188. 188.
    Clark RH. Support of gas exchange in the delivery room and beyond: how do we avoid hurting the baby we seek to save? Clin Perinatol. 1999;26:669–81.PubMedGoogle Scholar
  189. 189.
    Edwards MO, Kotecha SJ, Kotecha S. Respiratory distress of the term newborn infant. Paediatr Respir Rev. 2013;14:29–36.PubMedGoogle Scholar
  190. 190.
    Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357–68.PubMedPubMedCentralGoogle Scholar
  191. 191.
    Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946–55.PubMedGoogle Scholar
  192. 192.
    Van Lierde S, Cornelis A, Devlieger H, Moerman P, Lauweryns J, Eggermont E. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? A clinicopathologic study. Biol Neonate. 1991;60:152–62.PubMedGoogle Scholar
  193. 193.
    Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:179–84.PubMedPubMedCentralGoogle Scholar
  194. 194.
    Merritt TA, Deming DD, Boynton BR. The ‘new’ bronchopulmonary dysplasia: challenges and commentary. Semin Fetal Neonatal Med. 2009;14:345–57.PubMedGoogle Scholar
  195. 195.
    Bland RD. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate. 2005;88:181–91.PubMedGoogle Scholar
  196. 196.
    D’Angio CT, Ryan RM. Animal models of bronchopulmonary dysplasia. Iii: the preterm and term rabbit models. Am J Physiol Lung Cell Molecular Physiol. 2014. doi: 10.1152/ajplung 00228 02014.CrossRefGoogle Scholar
  197. 197.
    Crapo JD, Peters-Golden M, Marsh-Salin J, Shelburne JS. Pathologic changes in the lungs of oxygen-adapted rats: a morphometric analysis. Lab Invest. 1978;39:640–53.PubMedGoogle Scholar
  198. 198.
    Nash G, Blennerhassett JB, Pontoppidan H. Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Engl J Med. 1967;276:368–74.PubMedGoogle Scholar
  199. 199.
    Frank L, Sosenko IR. Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res. 1991;29:292–6.PubMedGoogle Scholar
  200. 200.
    Sosenko IR, Frank L. Guinea pig lung development: antioxidant enzymes and premature survival in high o2. Am J Physiol. 1987;252:R693–8.PubMedGoogle Scholar
  201. 201.
    Barnes ND, Hull D, Glover WJ, Milner AD. Effects of prolonged positive-pressure ventilation in infancy. Lancet. 1969;2:1096–9.PubMedGoogle Scholar
  202. 202.
    Tooley WH. Epidemiology of bronchopulmonary dysplasia. J Pediatr. 1979;95:851–8.PubMedGoogle Scholar
  203. 203.
    Taghizadeh A, Reynolds EO. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol. 1976;82:241–64.PubMedPubMedCentralGoogle Scholar
  204. 204.
    Lemyre B, Davis PG, De Paoli AG, Kirpalani H. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database of Syst Rev. 2014;(9): CD003212.Google Scholar
  205. 205.
    Steele RW, Metz JR, Bass JW, DuBois JJ. Pneumothorax and pneumomediastinum in the newborn. Radiology. 1971;98:629–32.PubMedGoogle Scholar
  206. 206.
    Madansky DL, Lawson EE, Chernick V, Taeusch Jr HW. Pneumothorax and other forms of pulmonary air leak in newborns. Am Rev Respir Dis. 1979;120:729–37.PubMedGoogle Scholar
  207. 207.
    Berg TJ, Pagtakhan RD, Reed MH, Langston C, Chernick V. Bronchopulmonary dysplasia and lung rupture in hyaline membrane disease: influence of continuous distending pressure. Pediatrics. 1975;55:51–4.PubMedGoogle Scholar
  208. 208.
    Greenough A, Morley CJ. Pneumothorax in infants who fight ventilators. Lancet. 1984;1:689.PubMedGoogle Scholar
  209. 209.
    Tarnow-Mordi W, Wilkinson A. High and conventional ventilation rates in the newborn. Arch Dis Child. 1985;60:395–6.PubMedPubMedCentralGoogle Scholar
  210. 210.
    Speer CP, Sweet DG, Halliday HL. Surfactant therapy: past, present and future. Early Hum Dev. 2013;89:S22–4.PubMedGoogle Scholar
  211. 211.
    Greenough A, Morley CJ, Pool J. Fighting the ventilator–are fast rates an effective alternative to paralysis? Early Hum Dev. 1986;13:189–94.PubMedGoogle Scholar
  212. 212.
    Field D, Milner AD, Hopkin IE. Manipulation of ventilator settings to prevent active expiration against positive pressure inflation. Arch Dis Child. 1985;60:1036–40.PubMedPubMedCentralGoogle Scholar
  213. 213.
    Cronin JH. High frequency ventilator therapy for newborns. J Intensive Care Med. 1994;9:71–85.PubMedGoogle Scholar
  214. 214.
    Plavka R, Dokoupilova M, Pazderova L, Kopecky P, Sebron V, Zapadlo M, et al. High-frequency jet ventilation improves gas exchange in extremely immature infants with evolving chronic lung disease. Am J Perinatol. 2006;23:467–72.PubMedGoogle Scholar
  215. 215.
    Drew JH, Landau LI, Acton CM, Kent M, Campbell PE. Pulmonary interstitial emphysema requiring lobectomy. Complications of assisted ventilation. Arch Dis Child. 1978;53:424–6.PubMedPubMedCentralGoogle Scholar
  216. 216.
    Greenough A, Dixon AK, Roberton NR. Pulmonary interstitial emphysema. Arch Dis Child. 1984;59:1046–51.PubMedPubMedCentralGoogle Scholar
  217. 217.
    Rastogi S, Gupta A, Wung JT, Berdon WE. Treatment of giant pulmonary interstitial emphysema by ipsilateral bronchial occlusion with a Swan-Ganz catheter. Pediatr Radiol. 2007;37:1130–4.PubMedGoogle Scholar
  218. 218.
    Milligan DW, Issler H, Massam M, Reynolds EO. Treatment of neonatal pulmonary interstitial emphysema by lung puncture. Lancet. 1984;1:1010–1.PubMedGoogle Scholar
  219. 219.
    Zerella JT, Trump DS. Surgical management of neonatal interstitial emphysema. J Pediatr Surg. 1987;22:34–7.PubMedGoogle Scholar
  220. 220.
    Lee SK, Tanswell AK. Pulmonary vascular air embolism in the newborn. Arch Dis Child. 1989;64:507–10.PubMedPubMedCentralGoogle Scholar
  221. 221.
    Bowen Jr FW, Chandra R, Avery GB. Pulmonary interstitial emphysema with gas embolism in hyaline membrane disease. Am J Diseases Child. 1973;126:117–8.Google Scholar
  222. 222.
    Chiu CJ, Golding MR, Linder JB, Fries CC. Pulmonary venous air embolism: a hemodynamic reappraisal. Surgery. 1967;61:816–9.PubMedGoogle Scholar
  223. 223.
    Divekar A, Cases R, Soni R. Echocardiographic characteristics of venous air embolism presenting as reversible pulmonary atresia in a premature neonate. Cardiol Young. 2004;14:102–5.PubMedGoogle Scholar
  224. 224.
    Spitzer AR, Butler S, Fox WW. Ventilatory response to combined high frequency jet ventilation and conventional mechanical ventilation for the rescue treatment of severe neonatal lung disease. Pediatr Pulmonol. 1989;7:244–50.PubMedGoogle Scholar
  225. 225.
    Mammel MC, Ophoven JP, Lewallen PK, Gordon MJ, Sutton MC, Boros SJ. High-frequency ventilation and tracheal injuries. Pediatrics. 1986;77:608–13.PubMedGoogle Scholar
  226. 226.
    Boros SJ, Mammel MC, Lewallen PK, Coleman JM, Gordon MJ, Ophoven J. Necrotizing tracheobronchitis: a complication of high-frequency ventilation. J Pediatr. 1986;109:95–100.PubMedGoogle Scholar
  227. 227.
    Chan KN, Chakrabarti MK, Whitwam JG, Silverman M. Assessment of a new valveless infant ventilator. Arch Dis Child. 1988;63:162–7.PubMedPubMedCentralGoogle Scholar
  228. 228.
    McShane D, Nicholson AG, Goldstraw P, Ladas G, Travis WD, Ramanan R, et al. Inflammatory endobronchial polyps in childhood: clinical spectrum and possible link to mechanical ventilation. Pediatr Pulmonol. 2002;34:79–84.PubMedGoogle Scholar
  229. 229.
    Bartlett RH, Gazzaniga AB, Huxtable RF, Schippers HC, O’Connor MJ, Jefferies MR. Extracorporeal circulation (ECMO) in neonatal respiratory failure. J Thorac Cardiovasc Surg. 1977;74:826–33.PubMedGoogle Scholar
  230. 230.
    Bartlett RH, Andrews AF, Toomasian JM, Haiduc NJ, Gazzaniga AB. Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery. 1982;92:425–33.PubMedGoogle Scholar
  231. 231.
    Varnholt V, Lasch P, Sartoris J, Koelfen W, Kachel W, Lorenz C, et al. Prognosis and outcome of neonates treated either with veno-arterial (VA) or veno-venous (VV) ECMO. Int J Artif Organs. 1995;18:569–73.PubMedGoogle Scholar
  232. 232.
    Andrews AF, Klein MD, Toomasian JM, Roloff DW, Bartlett RH. Venovenous extracorporeal membrane oxygenation in neonates with respiratory failure. J Pediatr Surg. 1983;18:339–46.PubMedGoogle Scholar
  233. 233.
    Klein MD, Andrews AF, Wesley JR, Toomasian J, Nixon C, Roloff D, et al. Venovenous perfusion in ECMO for newborn respiratory insufficiency. A clinical comparison with venoarterial perfusion. Ann Surg. 1985;201:520–6.PubMedPubMedCentralGoogle Scholar
  234. 234.
    Schumacher RE, Barks JD, Johnston MV, Donn SM, Scher MS, Roloff DW, et al. Right-sided brain lesions in infants following extracorporeal membrane oxygenation. Pediatrics. 1988;82:155–61.PubMedGoogle Scholar
  235. 235.
    Crombleholme TM, Adzick NS, deLorimier AA, Longaker MT, Harrison MR, Charlton VE. Carotid artery reconstruction following extracorporeal membrane oxygenation. Am J Dis Child. 1990;144:872–4.Google Scholar
  236. 236.
    Ijsselstijn H, van Heijst AF. Long-term outcome of children treated with neonatal extracorporeal membrane oxygenation: increasing problems with increasing age. Semin Perinatol. 2014;38:114–21.PubMedGoogle Scholar
  237. 237.
    Anonymous. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group. Lancet. 1996;348:75–82.Google Scholar
  238. 238.
    Pratt PC, Vollmer RT, Shelburne JD, Crapo JD. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am J Pathol. 1979;95:191–214.PubMedPubMedCentralGoogle Scholar
  239. 239.
    Hamutcu R, Nield TA, Garg M, Keens TG, Platzker AC. Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. Pediatrics. 2004;114:1292–6.PubMedGoogle Scholar
  240. 240.
    Bahrami KR, Van Meurs KP. ECMO for neonatal respiratory failure. Semin Perinatol. 2005;29:15–23.PubMedGoogle Scholar
  241. 241.
    Kugelman A, Gangitano E, Taschuk R, Garza R, Riskin A, McEvoy C, et al. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO. J Pediatr Surg. 2005;40:1082–9.PubMedGoogle Scholar
  242. 242.
    Weber TR, Kountzman B. The effects of venous occlusion on cerebral blood flow characteristics during ECMO. J Pediatr Surg. 1996;31:1124–7.PubMedGoogle Scholar
  243. 243.
    Graziani LJ, Baumgart S, Desai S, Stanley C, Gringlas M, Spitzer AR. Clinical antecedents of neurologic and audiologic abnormalities in survivors of neonatal extracorporeal membrane oxygenation. J Child Neurol. 1997;12:415–22.PubMedGoogle Scholar
  244. 244.
    McGahren ED, Mallik K, Rodgers BM. Neurological outcome is diminished in survivors of congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation. J Pediatr Surg. 1997;32:1216–20.PubMedGoogle Scholar
  245. 245.
    Bulas D, Glass P. Neonatal ECMO: neuroimaging and neurodevelopmental outcome. Semin Perinatol. 2005;29:58–65.PubMedGoogle Scholar
  246. 246.
    Mugford M, Elbourne D, Field D. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database of Syst Rev. 2008;(3):CD001340.Google Scholar
  247. 247.
    Khambekar K, Nichani S, Luyt DK, Peek G, Firmin RK, Field DJ, et al. Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience. Arch Dis Child Fetal Neonatal Ed. 2006;91:F21–5.PubMedPubMedCentralGoogle Scholar
  248. 248.
    Becker JA, Short BL, Martin GR. Cardiovascular complications adversely affect survival during extracorporeal membrane oxygenation. Crit Care Med. 1998;26:1582–6.PubMedGoogle Scholar
  249. 249.
    Paden ML, Rycus PT, Thiagarajan RR, ELSO Registry. Update and outcomes in extracorporeal life support. Semin Perinatol. 2014;38:65–70.PubMedGoogle Scholar
  250. 250.
    Hintz SR, Benitz WE, Colby CE, Sheehan AM, Rycus P, Van Meurs KP, et al. Utilization and outcomes of neonatal cardiac extracorporeal life support: 1996–2000. Pediatr Crit Care Med. 2005;6:33–8.PubMedGoogle Scholar
  251. 251.
    Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265–9.PubMedPubMedCentralGoogle Scholar
  252. 252.
    Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994;149:538–51.PubMedGoogle Scholar
  253. 253.
    Miller CL. Nitric oxide therapy for persistent pulmonary hypertension of the newborn. Neonatal Netw NN. 1995;14:9–15.PubMedGoogle Scholar
  254. 254.
    Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353:13–22.PubMedGoogle Scholar
  255. 255.
    Kinsella JP, Cutter GR, Steinhorn RH, Nelin LD, Walsh WF, Finer NN, et al. Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns. J Pediatr. 2014;165:1104–1108.PubMedPubMedCentralGoogle Scholar
  256. 256.
    Kinsella JP, Abman SH. Methaemoglobin during nitric oxide therapy with high-frequency ventilation. Lancet. 1993;342:615.PubMedGoogle Scholar
  257. 257.
    Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424.PubMedPubMedCentralGoogle Scholar
  258. 258.
    Weinberger B, Laskin DL, Heck DE, Laskin JD. The toxicology of inhaled nitric oxide. Toxicol Sci. 2001;59:5–16.PubMedGoogle Scholar
  259. 259.
    Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol. 1993;265:L555–64.PubMedGoogle Scholar
  260. 260.
    Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995;151:1250–4.PubMedGoogle Scholar
  261. 261.
    Matalon S, DeMarco V, Haddad IY, Myles C, Skimming JW, Schurch S, et al. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol. 1996;270:L273–80.PubMedGoogle Scholar
  262. 262.
    van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem. 1997;272:7617–25.PubMedGoogle Scholar
  263. 263.
    Tamir S, Burney S, Tannenbaum SR. DNA damage by nitric oxide. Chem Res Toxicol. 1996;9:821–7.PubMedGoogle Scholar
  264. 264.
    Sargent JW, Seffl RJ. Properties of perfluorinated liquids. Fed Proc. 1970;29:1699–703.PubMedGoogle Scholar
  265. 265.
    Wolfson MR, Shaffer TH. Pulmonary applications of perfluorochemical liquids: ventilation and beyond. Paediatr Respir Rev. 2005;6:117–27.PubMedGoogle Scholar
  266. 266.
    Kaushal A, McDonnell CG, Davies MW. Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev. 2013;(2):CD003845.Google Scholar
  267. 267.
    Lowe C, Tuma RF, Sivieri EM, Shaffer TH. Liquid ventilation: cardiovascular adjustments with secondary hyperlactatemia and acidosis. J Appl Physiol Respir Environ Exerc Physiol. 1979;47:1051–7.PubMedGoogle Scholar
  268. 268.
    Sivieri EM, Moskowitz GD, Shaffer TH. Instrumentation for measuring cardiac output by direct Fick method during liquid ventilation. Undersea Biomed Res. 1981;8:75–83.PubMedGoogle Scholar
  269. 269.
    Chida S, Phelps DS, Soll RF, Taeusch HW. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment. Pediatrics. 1991;88:84–9.PubMedGoogle Scholar
  270. 270.
    Stevenson D, Walther F, Long W, Sell M, Pauly T, Gong A, et al. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I. J Pediatr. 1992;120:S3–12.PubMedGoogle Scholar
  271. 271.
    van Houten J, Long W, Mullett M, Finer N, Derleth D, McMurray B, et al. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. J Pediatr. 1992;120:S40–4.PubMedGoogle Scholar
  272. 272.
    Raju TN, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr. 1993;123:603–10.PubMedGoogle Scholar
  273. 273.
    Anonymous. Early versus delayed neonatal administration of a synthetic surfactant – the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency – the role of surfactant. Lancet. 1992;340:1363–69.Google Scholar
  274. 274.
    Ellison P, Eichorst D, Rouse M, Heimler R, Denny J. Changes in cerebral hemodynamics in preterm infants with and without patent ductus arteriosus. Acta Paediatr Scand Suppl. 1983;311:23–7.PubMedGoogle Scholar
  275. 275.
    Gersony WM. Patent ductus arteriosus in the neonate. Pediatr Clin North Am. 1986;33:545–60.PubMedGoogle Scholar
  276. 276.
    Cifuentes RF, Olley PM, Balfe JW, Radde IC, Soldin SJ. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr. 1979;95:583–7.PubMedGoogle Scholar
  277. 277.
    Gordon PV. Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr Res. 2009;65:138–44.PubMedGoogle Scholar
  278. 278.
    Friedman WF, Fitzpatrick KM. Effects of prostaglandins, thromboxanes, and inhibitors of their synthesis on renal and gastrointestinal function in the newborn period. Semin Perinatol. 1980;4:143–56.PubMedGoogle Scholar
  279. 279.
    Corazza MS, Davis RF, Merritt TA, Bejar R, Cvetnic W. Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus. J Pediatr. 1984;105:292–6.PubMedGoogle Scholar
  280. 280.
    Pryds O, Greisen G, Johansen KH. Indomethacin and cerebral blood flow in premature infants treated for patent ductus arteriosus. Eur J Pediatr. 1988;147:315–6.PubMedGoogle Scholar
  281. 281.
    Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT, et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet. 1990;335:1491–5.PubMedGoogle Scholar
  282. 282.
    Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993;329:1602–7.PubMedGoogle Scholar
  283. 283.
    Souter D, Harding J, McCowan L, O’Donnell C, McLeay E, Baxendale H. Antenatal indomethacin–adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol. 1998;38:11–6.PubMedGoogle Scholar
  284. 284.
    Baerts W, van Bel F, Thewissen L, Derks JB, Lemmers PM. Tocolytic indomethacin: effects on neonatal haemodynamics and cerebral autoregulation in the preterm newborn. Arch Dis Child Fetal Neonatal Ed. 2013;98:F419–23.PubMedGoogle Scholar
  285. 285.
    Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res. 2000;47:36–42.PubMedGoogle Scholar
  286. 286.
    Brion LP, Bell EF, Raghuveer TS. Vitamin e supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003;(4):CD003665.Google Scholar
  287. 287.
    Johnson L, Bowen Jr FW, Abbasi S, Herrmann N, Weston M, Sacks L, et al. Relationship of prolonged pharmacologic serum levels of vitamin e to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics. 1985;75:619–38.PubMedGoogle Scholar
  288. 288.
    Moessinger AC, Driscoll Jr JM, Wigger HJ. High incidence of lung perforation by chest tube in neonatal pneumothorax. J Pediatr. 1978;92:635–7.PubMedGoogle Scholar
  289. 289.
    Kumar SP, Belik J. Chylothorax–a complication of chest tube placement in a neonate. Crit Care Med. 1984;12:411–2.PubMedGoogle Scholar
  290. 290.
    Quak JM, Szatmari A, van den Anker JN. Cardiac tamponade in a preterm neonate secondary to a chest tube. Acta Paediatr. 1993;82:490–1.PubMedGoogle Scholar
  291. 291.
    Ayalon A, Anner H, Moghilner M, Schiller M. Eventration of the diaphragm due to phrenic nerve injury caused by intercostal drainage. J Pediatr Surg. 1979;14:473–4.PubMedGoogle Scholar
  292. 292.
    Marinelli PV, Ortiz A, Alden ER. Acquired eventration of the diaphragm: a complication of chest tube placement in neonatal pneumothorax. Pediatrics. 1981;67:552–4.PubMedGoogle Scholar
  293. 293.
    Arya H, Williams J, Ponsford SN, Bissenden JG. Neonatal diaphragmatic paralysis caused by chest drains. Arch Dis Child. 1991;66:441–2.PubMedPubMedCentralGoogle Scholar
  294. 294.
    Berger JT, Gilhooly J. Fibrin glue treatment of persistent pneumothorax in a premature infant. J Pediatr. 1993;122:958–60.PubMedGoogle Scholar
  295. 295.
    Wesstrom G, Finnstrom O, Stenport G. Umbilical artery catheterization in newborns. I. Thrombosis in relation to catheter type and position. Acta Paediatr Scand. 1979;68:575–81.PubMedGoogle Scholar
  296. 296.
    Joshi VV, Draper DA, Bates 3rd RD. Neonatal necrotizing enterocolitis. Occurrence secondary to thrombosis of abdominal aorta following umbilical arterial catheterization. Arch Pathol. 1975;99:540–3.PubMedGoogle Scholar
  297. 297.
    Flanigan DP, Stolar CJ, Pringle KC, Schuler JJ, Fisher E, Vidyasager D. Aortic thrombosis after umbilical artery catheterization. Arch Surg. 1982;117:371–4.PubMedGoogle Scholar
  298. 298.
    Phelps DL. The umbilical artery catheter: prevention of bleeding after its removal. Pediatrics. 1972;50:164.PubMedGoogle Scholar
  299. 299.
    Kempley ST, Bennett S, Loftus BG, Cooper D, Gamsu HR. Randomized trial of umbilical arterial catheter position: clinical outcome. Acta Paediatr. 1993;82:173–6.PubMedGoogle Scholar
  300. 300.
    Mokrohisky ST, Levine RL, Blumhagen JD, Wesenberg RL, Simmons MA. Low positioning of umbilical-artery catheters increases associated complications in newborn infants. N Engl J Med. 1978;299:561–4.PubMedGoogle Scholar
  301. 301.
    Himmel PD, Sumner DS, Mongkolsmai C, Khanna N. Neonatal thoracoabdominal aortic thrombosis associated with the umbilical artery catheter: successful management by transaortic thrombectomy. J Vasc Surg. 1986;4:119–23.PubMedGoogle Scholar
  302. 302.
    Nagel K, Tuckuviene R, Paes B, Chan AK. Neonatal aortic thrombosis: a comprehensive review. Klin Padiatr. 2010;222:134–9.PubMedGoogle Scholar
  303. 303.
    Lin SJ, Koltz PF, Davis W, Vicari F. Lower extremity ischemia following umbilical artery catheterization: a case study and clinical update. Int J Surg. 2009;7:182–6.PubMedGoogle Scholar
  304. 304.
    Adelman RD, Morrell RE. Coarctation of the abdominal aorta and renal artery stenosis related to an umbilical artery catheter placement in a neonate. Pediatrics. 2000;106:E36.PubMedGoogle Scholar
  305. 305.
    Joseph R, Chong A, Teh M, Wee A, Tan KL. Thrombotic complication of umbilical arterial catheterization and its sequelae. Ann Acad Med Singapore. 1985;14:576–82.PubMedGoogle Scholar
  306. 306.
    Dmochowski RR, Crandell SS, Corriere Jr JN. Bladder injury and uroascites from umbilical artery catheterization. Pediatrics. 1986;77:421–2.PubMedGoogle Scholar
  307. 307.
    Cribari C, Meadors FA, Crawford ES, Coselli JS, Safi HJ, Svensson LG. Thoracoabdominal aortic aneurysm associated with umbilical artery catheterization: case report and review of the literature. J Vasc Surg. 1992;16:75–86.PubMedGoogle Scholar
  308. 308.
    Brown MS, Phibbs RH. Spinal cord injury in newborns from use of umbilical artery catheters: report of two cases and a review of the literature. J Perinatol. 1988;8:105–10.Google Scholar
  309. 309.
    Haldeman S, Fowler GW, Ashwal S, Schneider S. Acute flaccid neonatal paraplegia: a case report. Neurology. 1983;33:93–5.PubMedGoogle Scholar
  310. 310.
    Munoz ME, Roche C, Escriba R, Martinez-Bermejo A, Pascual-Castroviejo I. Flaccid paraplegia as complication of umbilical artery catheterization. Pediatr Neurol. 1993;9:401–3.PubMedGoogle Scholar
  311. 311.
    Vernooij CM, Hogeman PH, Nikkels PG, Blok CA, Brouwers HA. Necrosis of the left buttock as a complication of umbilical catheterisation in neonatal resuscitation. Arch Dis Child Fetal Neonatal Ed. 2007;92:F48.PubMedPubMedCentralGoogle Scholar
  312. 312.
    Mann NP. Gluteal skin necrosis after umbilical artery catheterisation. Arch Dis Child. 1980;55:815–7.PubMedPubMedCentralGoogle Scholar
  313. 313.
    De Curtis M, Mastropasqua S, Paludetto R, Orzalesi M. Gangrene of the buttock: a devastating complication of the infusion of hyperosmolar solutions in the umbilical artery at birth. Eur J Pediatr. 1985;144:261–2.PubMedGoogle Scholar
  314. 314.
    Wilkinson AR, Baum JD, Keeling JW. Superficial skin necrosis in babies prepared for umbilical arterial catheterisation. Arch Dis Child. 1981;56:237–8.PubMedPubMedCentralGoogle Scholar
  315. 315.
    Harpin V, Rutter N. Percutaneous alcohol absorption and skin necrosis in a preterm infant. Arch Dis Child. 1982;57:477–9.PubMedPubMedCentralGoogle Scholar
  316. 316.
    Simmons MA, Levine RL, Lubchenco LO, Guggenheim MA. Warning: serious sequelae of temporal artery catheterization. J Pediatr. 1978;92:284.PubMedGoogle Scholar
  317. 317.
    Lin PH, Dodson TF, Bush RL, Weiss VJ, Conklin BS, Chen C, et al. Surgical intervention for complications caused by femoral artery catheterization in pediatric patients. J Vasc Surg. 2001;34:1071–8.PubMedGoogle Scholar
  318. 318.
    Gamba P, Tchaprassian Z, Verlato F, Verlato G, Orzali A, Zanon GF. Iatrogenic vascular lesions in extremely low birth weight and low birth weight neonates. J Vasc Surg. 1997;26:643–6.PubMedGoogle Scholar
  319. 319.
    Kitterman JA, Phibbs RH, Tooley WH. Catheterization of umbilical vessels in newborn infants. Pediatr Clin North Am. 1970;17:895–912.PubMedGoogle Scholar
  320. 320.
    Walker D, Pellett JR. Pericardial tamponade secondary to umbilical vein catheters. J Pediatr Surg. 1972;7:79–80.PubMedGoogle Scholar
  321. 321.
    Abdellatif M, Ahmed A, Alsenaidi K. Cardiac tamponade due to umbilical venous catheter in the newborn. BMJ Case Reports 2012; doi: 10.1136/bcr-2012-6160.Google Scholar
  322. 322.
    Larroche JC. Umbilical catheterization: its complications. Anatomical study. Biol Neonate. 1970;16:101–16.PubMedGoogle Scholar
  323. 323.
    Junker P, Egeblad M, Nielsen O, Kamper J. Umbilical vein catheterization and portal hypertension. Acta Paediatr Scand. 1976;65:499–504.PubMedGoogle Scholar
  324. 324.
    Lauridsen UB, Enk B, Gammeltoft A. Oesophageal varices as a late complication to neonatal umbilical vein catheterization. Acta Paediatr Scand. 1978;67:633–6.PubMedGoogle Scholar
  325. 325.
    Harden JL, Kemp L, Mirtallo J. Femoral catheters increase risk of infection in total parenteral nutrition patients. Nutr Clin Pract. 1995;10:60–6.PubMedGoogle Scholar
  326. 326.
    Nowlen TT, Rosenthal GL, Johnson GL, Tom DJ, Vargo TA. Pericardial effusion and tamponade in infants with central catheters. Pediatrics. 2002;110:137–42.PubMedGoogle Scholar
  327. 327.
    Mohrenschlager M, Weigl LB, Haug S, Schnopp C, Cremer H, Ring J, et al. Iatrogenic burns by warming bottles in the neonatal period: report of two cases and review of the literature. J Burn Care Rehabil. 2003;24:52–5.Google Scholar
  328. 328.
    Perman MJ, Kauls LS. Transilluminator burns in the neonatal intensive care unit: a mimicker of more serious disease. Pediatr Dermatol. 2007;24:168–71.PubMedGoogle Scholar
  329. 329.
    Simonsen K, Graem N, Rothman LP, Degn H. Iatrogenic radiant heat burns in severely asphyxic newborns. Acta Paediatr. 1995;84:1438–40.PubMedGoogle Scholar
  330. 330.
    Kimbrough RD, Gaines TB. Hexachlorophene effects on the rat brain: study of high doses by light and electron microscopy. Arch Environ Health. 1971;23:114–8.PubMedGoogle Scholar
  331. 331.
    Powell H, Swarner O, Gluck L, Lampert P. Hexachlorophene myelinopathy in premature infants. J Pediatr. 1973;82:976–81.PubMedGoogle Scholar
  332. 332.
    Shuman RM, Leech RW, Alvord Jr EC. Neurotoxicity of hexachlorophene in the human: I. A clinicopathologic study of 248 children. Pediatrics. 1974;54:689–95.PubMedGoogle Scholar
  333. 333.
    Halliday HL. Useless perinatal therapies. Neonatology. 2010;97:358–65.PubMedGoogle Scholar
  334. 334.
    Koren G, Barzilay Z, Greenwald M. Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics. 1986;77:848–9.PubMedGoogle Scholar
  335. 335.
    Jonville AP, Autret E, Bavoux F, Bertrand PP, Barbier P, Gauchez AS. Characteristics of medication errors in pediatrics. DICP Ann Pharmacother. 1991;25:1113–8.Google Scholar
  336. 336.
    Conroy S, Sweis D, Planner C, Yeung V, Collier J, Haines L, et al. Interventions to reduce dosing errors in children: a systematic review of the literature. Drug Saf Int J Med Toxicol Drug Experience. 2007;30:1111–25.Google Scholar
  337. 337.
    Wong IC, Wong LY, Cranswick NE. Minimising medication errors in children. Arch Dis Child. 2009;94:161–4.PubMedGoogle Scholar
  338. 338.
    Zaffanello M, Bassareo PP, Cataldi L, Antonucci R, Biban P, Fanos V. Long-term effects of neonatal drugs on the kidney. J Matern-Fetal Neonatal Med. 2010;23:87–9.Google Scholar
  339. 339.
    Fanos V, Cataldi L. Drug misadventuring in neonatal nephrology. Pediatr Med Chir Med Surg Pediatr. 2002;24:150–6.Google Scholar
  340. 340.
    Kao LC, Durand DJ, McCrea RC, Birch M, Powers RJ, Nickerson BG. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr. 1994;124:772–81.PubMedGoogle Scholar
  341. 341.
    Najak ZD, Harris EM, Lazzara Jr A, Pruitt AW. Pulmonary effects of furosemide in preterm infants with lung disease. J Pediatr. 1983;102:758–63.PubMedGoogle Scholar
  342. 342.
    Albersheim SG, Solimano AJ, Sharma AK, Smyth JA, Rotschild A, Wood BJ, et al. Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia. J Pediatr. 1989;115:615–20.PubMedGoogle Scholar
  343. 343.
    Segar JL. Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. Clin Perinatol. 2012;39:209–20.PubMedGoogle Scholar
  344. 344.
    Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics. 1982;70:360–3.PubMedGoogle Scholar
  345. 345.
    Ezzedeen F, Adelman RD, Ahlfors CE. Renal calcification in preterm infants: pathophysiology and long-term sequelae. J Pediatr. 1988;113:532–9.PubMedGoogle Scholar
  346. 346.
    McCann EM, Lewis K, Deming DD, Donovan MJ, Brady JP. Controlled trial of furosemide therapy in infants with chronic lung disease. J Pediatr. 1985;106:957–62.PubMedGoogle Scholar
  347. 347.
    DeRubertis FR, Michelis MF, Beck N, Davis BB. Complications of diuretic therapy: severe alkalosis and syndrome resembling inappropriate secretion of antidiuretic hormone. Metab Clin Exper. 1970;19:709–19.Google Scholar
  348. 348.
    Rybak LP. Pathophysiology of furosemide ototoxicity. J Otolaryngol. 1982;11:127–33.PubMedGoogle Scholar
  349. 349.
    Salamy A, Eldredge L, Tooley WH. Neonatal status and hearing loss in high-risk infants. J Pediatr. 1989;114:847–52.PubMedGoogle Scholar
  350. 350.
    Anonymous. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Collaborative Dexamethasone Trial Group. Pediatrics. 1991;88:421–27.Google Scholar
  351. 351.
    Cummings JJ, D’Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989;320:1505–10.PubMedGoogle Scholar
  352. 352.
    Gunn T, Reece ER, Metrakos K, Colle E. Depressed t cells following neonatal steroid treatment. Pediatrics. 1981;67:61–7.PubMedGoogle Scholar
  353. 353.
    Ng PC, Thomson MA, Dear PR. Dexamethasone and infection in preterm babies: a controlled study. Arch Dis Child. 1990;65:54–6.PubMedPubMedCentralGoogle Scholar
  354. 354.
    Ng PC, Brownlee KG, Dear PR. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. Arch Dis Child. 1991;66:1164–6.PubMedPubMedCentralGoogle Scholar
  355. 355.
    O’Neil EA, Chwals WJ, O’Shea MD, Turner CS. Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. Arch Dis Child. 1992;67:10–1.PubMedPubMedCentralGoogle Scholar
  356. 356.
    Greenough A, Emery EF, Gamsu HR. Dexamethasone and hypertension in preterm infants. Eur J Pediatr. 1992;151:134–5.PubMedGoogle Scholar
  357. 357.
    Emery EF, Greenough A. Effect of dexamethasone on blood pressure–relationship to postnatal age. Eur J Pediatr. 1992;151:364–6.PubMedGoogle Scholar
  358. 358.
    Brand PL, van Lingen RA, Brus F, Talsma MD, Elzenga NJ. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia. Acta Paediatr. 1993;82:614–7.PubMedGoogle Scholar
  359. 359.
    Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr. 1992;120:286–91.PubMedGoogle Scholar
  360. 360.
    Brownlee KG, Ng PC, Henderson MJ, Smith M, Green JH, Dear PR. Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child. 1992;67:1–4.PubMedPubMedCentralGoogle Scholar
  361. 361.
    Williams AF, Jones M. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia. Arch Dis Child. 1992;67:5–9.PubMedPubMedCentralGoogle Scholar
  362. 362.
    Rennie JM, Baker B, Lucas A. Does dexamethasone suppress the ACTH response in preterm babies? Arch Dis Child. 1989;64:612–3.PubMedPubMedCentralGoogle Scholar
  363. 363.
    Rizvi ZB, Aniol HS, Myers TF, Zeller WP, Fisher SG, Anderson CL. Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr. 1992;120:961–5.PubMedGoogle Scholar
  364. 364.
    Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, et al. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav. 1994;28:336–48.PubMedGoogle Scholar
  365. 365.
    Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004;350:1304–13.PubMedGoogle Scholar
  366. 366.
    Benders MJ, Groenendaal F, van Bel F, Ha Vinh R, Dubois J, Lazeyras F, et al. Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease. Pediatr Res. 2009;66:555–9.PubMedPubMedCentralGoogle Scholar
  367. 367.
    Watterberg K. Evidence-based neonatal pharmacotherapy: postnatal corticosteroids. Clin Perinatol. 2012;39:47–59.PubMedGoogle Scholar
  368. 368.
    Butt W, Auldist A, McDougall P, Duncan A. Duodenal ulceration: a complication of tolazoline therapy. Aust Paediatr J. 1986;22:221–3.PubMedGoogle Scholar
  369. 369.
    Abu-Osba YK. Treatment of persistent pulmonary hypertension of the newborn: update. Arch Dis Child. 1991;66:74–7.PubMedPubMedCentralGoogle Scholar
  370. 370.
    Heffelfinger S, Hawkins EP, Nihill M, Langston C. Pulmonary vascular changes associated with prolonged prostaglandin E1 treatment. Pediatr Pathol. 1987;7:165–73.Google Scholar
  371. 371.
    Gardiner JS, Zauk AM, Donchey SS, McInerney VK. Prostaglandin-induced cortical hyperostosis. Case report and review of the literature. J Bone Joint Surg Am. 1995;77:932–6.PubMedGoogle Scholar
  372. 372.
    Talosi G, Katona M, Turi S. Side-effects of long-term prostaglandin E(1) treatment in neonates. Pediatr Int. 2007;49:335–40.PubMedGoogle Scholar
  373. 373.
    Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr. 1971;78:180–1.PubMedGoogle Scholar
  374. 374.
    Cohen C, Olsen MM. Pediatric total parenteral nutrition. Liver histopathology. Arch Pathol Lab Med. 1981;105:152–6.PubMedGoogle Scholar
  375. 375.
    Benjamin DR. Hepatobiliary dysfunction in infants and children associated with long-term total parenteral nutrition. A clinico-pathologic study. Am J Clin Pathol. 1981;76:276–83.PubMedGoogle Scholar
  376. 376.
    Naini BV, Lassman CR. Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation. Hum Pathol. 2012;43:826–33.Google Scholar
  377. 377.
    Arsenault DA, Potemkin AK, Robinson EM, Fallon EM, Ozonoff A, de Meijer VE, et al. Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury. J Pediatr Surg. 2011;46:122–7.PubMedGoogle Scholar
  378. 378.
    Barson AJ, Chistwick ML, Doig CM. Fat embolism in infancy after intravenous fat infusions. Arch Dis Child. 1978;53:218–23.PubMedPubMedCentralGoogle Scholar
  379. 379.
    Periera GR, Fox WW, Stanley CA, Baker L, Schwartz JG. Decreased oxygenation and hyperlipemia during intravenous fat infusions in premature infants. Pediatrics. 1980;66:26–30.PubMedGoogle Scholar
  380. 380.
    Hammerman C, Aramburo MJ. Decreased lipid intake reduces morbidity in sick premature neonates. J Pediatr. 1988;113:1083–8.PubMedGoogle Scholar
  381. 381.
    Sosenko IR, Rodriguez-Pierce M, Bancalari E. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr. 1993;123:975–82.PubMedGoogle Scholar
  382. 382.
    Cooke RW. Factors associated with chronic lung disease in preterm infants. Arch Dis Child. 1991;66:776–9.PubMedPubMedCentralGoogle Scholar
  383. 383.
    Katz S, Plaisier BR, Folkening WJ, Grosfeld JL. Intralipid adversely affects reticuloendothelial bacterial clearance. J Pediatr Surg. 1991;26:921–4.PubMedGoogle Scholar
  384. 384.
    Fischer GW, Hunter KW, Wilson SR, Mease AD. Diminished bacterial defences with intralipid. Lancet. 1980;2:819–20.PubMedGoogle Scholar
  385. 385.
    Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman J. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J. 1998;17:10–7.PubMedGoogle Scholar
  386. 386.
    Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med. 1990;323:301–8.PubMedGoogle Scholar
  387. 387.
    Yu VY. Principles and practice of parenteral nutrition in the neonatal period. Acta Med Port. 1997;10:185–96.PubMedGoogle Scholar
  388. 388.
    MacPherson T, Shen-Schwarz S, Valdes-Dapena M. Prevention and reduction of iatrogenic disorders in the newborn. In: Guthrie R, ed. Clinics in critical care medicine: recent advances in neonatal intensive care. New York: Churchill Livingstone; 1988. p. 271–312.Google Scholar
  389. 389.
    Stainsby D, Jones H, Wells AW, Gibson B, Cohen H, SHOT Steering Group. Adverse outcomes of blood transfusion in children: analysis of uk reports to the serious hazards of transfusion scheme 1996–2005. Br J Haematol. 2008;141:73–9.PubMedGoogle Scholar
  390. 390.
    Gresens CJ, Holland PV. Current risks of viral hepatitis from blood transfusions. J Gastroenterol Hepatol. 1998;13:443–9.PubMedGoogle Scholar
  391. 391.
    Luban NL. Review of neonatal red cell transfusion practices. Blood Rev. 1994;8:148–53.PubMedGoogle Scholar
  392. 392.
    Chamberland ME, Alter HJ, Busch MP, Nemo G, Ricketts M. Emerging infectious disease issues in blood safety. Emerg Infect Dis. 2001;7:552–3.PubMedPubMedCentralGoogle Scholar
  393. 393.
    Prati D, Capelli C, Rebulla P, Mozzi F, Bosoni P, De Mattei C, et al. The current risk of retroviral infections transmitted by transfusion in patients who have undergone multiple transfusions. Cooleycare cooperative group. Arch Intern Med. 1998;158:1566–9.PubMedGoogle Scholar
  394. 394.
    Dike AE, Christie JM, Kurtz JB, Teo CG. Hepatitis C in blood transfusion recipients identified at the oxford blood centre in the national hcv look-back programme. Transfus Med. 1998;8:87–95.PubMedGoogle Scholar
  395. 395.
    Aggarwal V, Prakash C, Yadav S, Chattopadhya D. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood. Southeast Asian J Trop Med Public Health. 1997;28:699–706.PubMedGoogle Scholar
  396. 396.
    Hume HA, Preiksaitis JB. Transfusion associated graft-versus-host disease, cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients. Transfus Sci. 1999;21:73–95.PubMedGoogle Scholar
  397. 397.
    Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood. 1995;86:3598–603.PubMedGoogle Scholar
  398. 398.
    Ruhl H, Bein G, Sachs UJ. Transfusion-associated graft-versus-host disease. Transfus Med Rev. 2009;23:62–71.PubMedGoogle Scholar
  399. 399.
    Ryan S. Nutritional aspects of metabolic bone disease in the newborn. Arch Dis Child Fetal Neonatal Ed. 1996;74:F145–8.PubMedPubMedCentralGoogle Scholar
  400. 400.
    Venkataraman PS, Tsang RC, Chen IW, Sperling MA. Pathogenesis of early neonatal hypocalcemia: studies of serum calcitonin, gastrin, and plasma glucagon. J Pediatr. 1987;110:599–603.PubMedGoogle Scholar
  401. 401.
    Mitchell SM, Rogers SP, Hicks PD, Hawthorne KM, Parker BR, Abrams SA. High frequencies of elevated alkaline phosphatase activity and rickets exist in extremely low birth weight infants despite current nutritional support. BMC Pediatr. 2009;9:47.PubMedPubMedCentralGoogle Scholar
  402. 402.
    Pieltain C, de Halleux V, Senterre T, Rigo J. Prematurity and bone health. World Rev Nutr Diet. 2013;106:181–8.PubMedGoogle Scholar

Copyright information

© Springer International Publishing 2015

Authors and Affiliations

  1. 1.Department of PathologyUniversity Hospital UtrechtUtrechtThe Netherlands

Personalised recommendations